What it sells
Don't die of heart disease. Empirical is the first AI-native heart…
Business model breakdown
Buyer: who owns the budget?
Individual consumers (HSA/FSA eligible); employer benefits teams for 500+ employee firms.
Trigger: what makes them buy now?
Concern about heart-attack risk and cholesterol markers (ApoB, Lp(a)) that primary care rarely orders.
Workflow: what inputs become what output?
Order 100+ biomarker panel, blood draw at one of 2,200+ locations, results in app with risk scores, then clinician guidance, repeated twice a year.
Economics: what it saves and how it charges
Consumer lab-test/membership revenue plus B2B employer and benefits-consultant volume deals.
Distribution: how it reaches customers
Self-serve app/web signup, comparison/SEO pages, employer and benefits-consultant partnerships.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.